Status:
COMPLETED
Comparison of the Combination of Fenofibrate and 20 mg Simvastatin Versus 40 mg Simvastatin Monotherapy
Lead Sponsor:
Solvay Pharmaceuticals
Conditions:
Hyperlipidemia
Eligibility:
All Genders
18-75 years
Phase:
PHASE3
Brief Summary
Mixed or combined hyperlipidemia is a common metabolic disorder characterized by both hypercholesterolemia and hypertriglyceridemia. Statins and fibrates have complementary mechanisms and can be coadm...
Eligibility Criteria
Inclusion
- Mixed dyslipidemia
Exclusion
- Known hypersensitivity to fenofibrate or simvastatin
- Pregnant or lactating women
- Contra-indication to fenofibrate or simvastatin
- Unstable or severe cardiac disease
Key Trial Info
Start Date :
November 1 2005
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
September 1 2008
Estimated Enrollment :
1040 Patients enrolled
Trial Details
Trial ID
NCT00349375
Start Date
November 1 2005
End Date
September 1 2008
Last Update
July 8 2009
Active Locations (110)
Enter a location and click search to find clinical trials sorted by distance.
1
Site 008
Brno, Czechia
2
Site 009
Brno, Czechia
3
Site 010
Brno, Czechia
4
Site 015
Hradisk, Czechia